TrialBritish journal of clinical pharmacology2023

Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19: A phase 2a, open-label, single-dose escalation study.

Manon L M Prins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.